title: Effect of ruboxistaurin on urinary transforming growth factor-beta in patients with diabetic nephropathy and type 2 diabetes.
authors.affiliation: Department of Medicine, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada. richard.gilbert@utoronto.ca
authors.forename: Richard E
authors.initials: RE
authors.lastname: Gilbert
authors.forename: Sandra A
authors.initials: SA
authors.lastname: Kim
authors.forename: Katherine R
authors.initials: KR
authors.lastname: Tuttle
authors.forename: George L
authors.initials: GL
authors.lastname: Bakris
authors.forename: Robert D
authors.initials: RD
authors.lastname: Toto
authors.forename: Janet B
authors.initials: JB
authors.lastname: McGill
authors.forename: Douglas J
authors.initials: DJ
authors.lastname: Haney
authors.forename: Darren J
authors.initials: DJ
authors.lastname: Kelly
authors.forename: Pamela W
authors.initials: PW
authors.lastname: Anderson
mesh_terms: D000328:Adult; D003404:Creatinine / Q000652:urine; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy / Q000652:urine*; D003928:Diabetic Nephropathies / Q000188:drug therapy* / Q000652:urine*; D004311:Double-Blind Method; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D008301:Maleimides / Q000627:therapeutic use*; D008875:Middle Aged; D010919:Placebos; D011493:Protein Kinase C / Q000037:antagonists & inhibitors; D064546:Protein Kinase C beta; D016212:Transforming Growth Factor beta / Q000235:genetics* / Q000652:urine
chemical_list: D004791:Enzyme Inhibitors; D007211:Indoles; D008301:Maleimides; D010919:Placebos; D016212:Transforming Growth Factor beta; C099154:ruboxistaurin; D003404:Creatinine; D011493:Protein Kinase C; D064546:Protein Kinase C beta